Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Uxin (UXIN) Gains from Sales and Divestitures (2018 - 2025)

Uxin filings provide 8 years of Gains from Sales and Divestitures readings, the most recent being $7.8 million for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures changed N/A to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a N/A change, with the full-year FY2025 number at $7.8 million, changed N/A from a year prior.
  • Gains from Sales and Divestitures hit $7.8 million in Q4 2025 for Uxin, up from $401536.3 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $7.8 million in Q4 2025 to a low of $47698.0 in Q1 2021.
  • Median Gains from Sales and Divestitures over the past 5 years was $401536.3 (2024), compared with a mean of $1.7 million.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 564.89% in 2021 and later decreased 3.42% in 2024.
  • Uxin's Gains from Sales and Divestitures stood at $47698.0 in 2021, then soared by 100.37% to $95571.4 in 2022, then surged by 335.02% to $415750.5 in 2023, then decreased by 3.42% to $401536.3 in 2024, then soared by 1838.27% to $7.8 million in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $7.8 million (Q4 2025), $401536.3 (Q1 2024), and $415750.5 (Q1 2023) per Business Quant data.